Clinical trial

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary…

NCT00300131 · Abbott Medical Devices, Industry · Completed

Key facts

NCT number NCT00300131
Title ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation
Official title Bioabsorbable Vascular Solutions First in Man Clinical Investigation: A Clinical Evaluation of the Bioabsorbable Vascular Solutions Everolimus Eluting Coronary Stent System (BVS EECSS) in the Treatment of Patients With Single de Novo Native Coronary Artery Lesions
Acronym ABSORB A
Lead sponsor Abbott Medical Devices, Industry
Status Completed
Study type Observational
Conditions Coronary Disease, Coronary Artery Disease, Coronary Restenosis
Intervention type Device
Interventions Bioabsorbable Everolimus Eluting Coronary Stent
Enrollment 30
Start date Mar 1, 2006
Primary completion Jul 1, 2011
Completion Jul 1, 2011
First posted Mar 8, 2006
Last update posted Sep 13, 2011
Countries Denmark, Netherlands, New Zealand, Poland

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies